Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: Among

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Neftaly Vutisani Malatjie

in

  • Neftaly To maintain VL at 95% among people who are on ART by 2026

    Neftaly To maintain VL at 95% among people who are on ART by 2026

  • Neftaly Increase viral supression among PLHIV to 86% by 2025.

    Neftaly Increase viral supression among PLHIV to 86% by 2025.

  • Neftaly To maintain low HIV prevalence in Macedonia, particularly among most-at-risk populations (MARPS)

    Neftaly To maintain low HIV prevalence in Macedonia, particularly among most-at-risk populations (MARPS)

  • Neftaly Increasing capacity and coordination of a focused response to HIV among most-at-risk populations

    Neftaly Increasing capacity and coordination of a focused response to HIV among most-at-risk populations

  • Neftaly Prevention of HIV transmission among most-at-risk populations

    Neftaly Prevention of HIV transmission among most-at-risk populations

  • Neftaly Strengthening HIV surveillance system among most-at-risk populations

    Neftaly Strengthening HIV surveillance system among most-at-risk populations

  • Neftaly Strengthening of community systems for sustained HIV response among people who inject drugs in Eastern Africa

    Neftaly Strengthening of community systems for sustained HIV response among people who inject drugs in Eastern Africa

    Neftaly: Strengthening Community Systems for a Sustained HIV Response Among People Who Inject Drugs in Eastern Africa

    Overview

    Neftaly recognizes the vital role that community systems play in driving sustainable, effective HIV responses — particularly among marginalized populations such as people who inject drugs (PWID). In Eastern Africa, stigma, criminalization, and limited access to harm reduction services continue to hinder HIV prevention and treatment outcomes for PWID. Through community system strengthening (CSS), Neftaly aims to empower local structures, networks, and civil society to lead and sustain high-impact interventions for PWID in the region.

    Objective

    To build resilient, inclusive, and community-led systems that effectively support and sustain the HIV response for people who inject drugs in Eastern Africa, while advancing rights-based and harm reduction approaches.

    Strategic Focus Areas

    1. Capacity Building of Community-Based Organizations (CBOs)

    • Support CBOs and peer-led networks with training in HIV service delivery, harm reduction, advocacy, and monitoring.
    • Enhance organizational management skills including governance, resource mobilization, and strategic planning.
    • Facilitate the formal recognition of PWID-led organizations in national HIV and health structures.

    2. Community-Led Service Delivery

    • Scale up community-based HIV testing, needle and syringe programs (NSPs), opioid substitution therapy (OST), and linkage to ART.
    • Expand outreach through mobile clinics, peer educators, and safe consumption spaces.
    • Integrate HIV services with mental health, TB care, hepatitis management, and overdose prevention.

    3. Policy Advocacy and Legal Literacy

    • Equip communities with the tools to advocate for drug policy reform and the decriminalization of drug use.
    • Train peer educators and outreach workers to provide legal literacy and referrals to rights-based support services.
    • Engage communities in national consultations and policy dialogues to ensure meaningful participation of PWID.

    4. Strengthening Community Monitoring and Accountability

    • Support the use of community-led monitoring tools to assess service quality, accessibility, and gaps.
    • Facilitate feedback mechanisms between communities, service providers, and governments.
    • Promote data-driven advocacy using real-time evidence collected from the community level.

    5. Enhancing Partnerships and Coordination

    • Foster partnerships between CBOs, national AIDS programs, health ministries, law enforcement, and regional bodies.
    • Support South-to-South collaboration and knowledge exchange among Eastern African countries on effective community-led models.
    • Facilitate inclusion of PWID representatives in decision-making platforms and funding mechanisms.

    Outcomes and Impact

    • Improved access to and retention in HIV services for PWID across Eastern Africa.
    • Stronger, more resilient community systems that can lead, sustain, and expand harm reduction interventions.
    • Empowered and organized PWID communities that are actively shaping national and regional HIV responses.
    • Policy environments that support public health–driven approaches, reduce stigma, and uphold human rights.

    Conclusion

    Neftaly’s approach to strengthening community systems is rooted in the belief that sustainable HIV responses must be led by those most affected. By equipping PWID communities in Eastern Africa with the tools, platforms, and partnerships they need, Neftaly is building a future where no one is left behind in the fight against HIV.

  • Neftaly To promote the strategic use of ICT and media to effectively scale up the HIV response among MSM and TG

    Neftaly To promote the strategic use of ICT and media to effectively scale up the HIV response among MSM and TG

    Neftaly: Promoting the Strategic Use of ICT and Media to Scale Up the HIV Response Among MSM and Transgender Communities

    Overview

    In an increasingly digital world, information and communication technologies (ICT) and media platforms offer powerful tools to expand the reach, accessibility, and impact of HIV interventions. Neftaly is committed to harnessing these technologies strategically to enhance HIV prevention, testing, treatment, and advocacy efforts targeting men who have sex with men (MSM) and transgender (TG) communities. By leveraging ICT and media, we aim to overcome barriers such as stigma, discrimination, and geographic isolation, fostering a more inclusive and effective HIV response.

    Goal

    To promote and support the strategic use of ICT and media to improve the scale, quality, and accessibility of HIV services and community engagement for MSM and TG populations.

    Strategic Objectives

    1. Expand Digital Platforms for HIV Service Delivery

    • Develop and scale user-friendly digital tools for HIV education, risk reduction messaging, appointment reminders, and virtual counseling tailored for MSM and TG communities.
    • Support online HIV testing promotion, self-testing distribution, and telemedicine consultations to increase testing and linkage to care.
    • Use mobile health (mHealth) applications to facilitate adherence support and peer-to-peer communication.

    2. Enhance Media Campaigns to Reduce Stigma and Promote Health-Seeking Behavior

    • Design culturally relevant, positive media content that promotes HIV awareness, testing, treatment, and the rights of MSM and TG individuals.
    • Engage social influencers, bloggers, and community leaders in spreading key HIV messages and challenging stigma and discrimination.
    • Use multimedia formats—videos, podcasts, social media stories—to reach diverse audiences effectively.

    3. Build Capacity for ICT and Media Use Among CBOs and Networks

    • Provide training for community organizations on digital literacy, social media management, content creation, and online advocacy.
    • Equip MSM and TG-led groups with skills to monitor and evaluate the impact of digital HIV interventions.
    • Support the development of community-led digital campaigns that amplify the voices and experiences of key populations.

    4. Foster Safe and Inclusive Online Spaces

    • Promote digital safety and privacy measures to protect MSM and TG users from harassment, discrimination, or data breaches.
    • Encourage the creation of online peer support groups and forums that provide confidential, stigma-free environments for sharing experiences and information.
    • Collaborate with tech partners to address online hate speech and discrimination against sexual and gender minorities.

    5. Strengthen Data Use and Innovation

    • Utilize data analytics from digital platforms to better understand HIV risk behaviors and service uptake among MSM and TG populations.
    • Support innovation labs and pilot projects exploring emerging technologies such as AI chatbots, virtual reality education, and geosocial networking for targeted outreach.
    • Promote regional knowledge exchange on best practices for ICT and media use in HIV programming.

    Expected Outcomes

    • Increased uptake of HIV prevention, testing, and treatment services facilitated by accessible and engaging digital tools.
    • Reduced stigma and enhanced community empowerment through positive and inclusive media narratives.
    • Stronger digital capacities within MSM and TG community organizations to drive sustained HIV responses.
    • Safer online environments that foster peer support and promote health equity.

    Conclusion

    Neftaly recognizes that ICT and media are catalysts for transformative change in HIV programming among MSM and transgender communities. By strategically integrating digital technologies and media outreach, we are expanding the reach and quality of services, amplifying community voices, and challenging the barriers that limit health and human rights. Together, we can harness innovation to create a more inclusive and effective HIV response.

  • Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.

    Neftaly Tuberculosis (TB) Treatment Success Enhancement Initiative

    Goal:
    To increase the TB treatment success rate among drug-susceptible patients from 85% in 2017 to 90% by 2020.

    Project Overview:
    The Neftaly TB initiative aimed to strengthen treatment adherence and quality of care for patients with drug-susceptible tuberculosis (DS-TB). Focused on improving treatment outcomes, the project implemented patient-centered support systems, strengthened health service delivery, and enhanced monitoring mechanisms to reduce loss to follow-up and treatment failure.

    Objectives:

    • To improve adherence to TB treatment regimens through community-based support and follow-up.
    • To reduce default rates by addressing barriers such as stigma, misinformation, and lack of access to care.
    • To train healthcare providers on patient management, counseling, and side-effect monitoring.
    • To implement real-time tracking and reporting systems to ensure continuous patient engagement and support.
    • To strengthen the Directly Observed Treatment, Short-course (DOTS) strategy through better supervision and community involvement.

    Key Interventions:

    • Deployment of community health workers and peer supporters to provide regular follow-ups and counseling.
    • Integration of nutritional and psychosocial support for vulnerable TB patients.
    • Use of digital adherence technologies (e.g., SMS reminders, phone-based follow-up) to reinforce treatment compliance.
    • Strengthening of TB recording and reporting tools to track patient outcomes accurately.
    • Coordination with national TB programs and local partners to align with broader public health goals.

    Impact:

    • Improved treatment adherence and reduced loss to follow-up.
    • Increased patient satisfaction and trust in the health system.
    • Enhanced capacity of healthcare providers to deliver patient-centered TB care.
    • Achievement of a treatment success rate approaching or exceeding the 90% target by 2020.
    • Contribution to national and global TB elimination strategies through sustainable, scalable practices.
  • Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly To achieve 90% viral suppression among PLHIVs on ART by 2021.

    Neftaly: Achieving 90% Viral Suppression Among PLHIV on ART

    Overview

    Viral suppression is a critical indicator of the success of antiretroviral therapy (ART) and a cornerstone of efforts to control the HIV epidemic. When people living with HIV (PLHIV) maintain suppressed viral loads, their health outcomes improve, the risk of HIV transmission is drastically reduced, and the burden on the health system is eased. Neftaly is committed to supporting the national HIV response to achieve 90% viral suppression among PLHIV on ART, in alignment with global targets and national strategic plans.

    Goal

    To ensure that 90% of people living with HIV receiving ART achieve and maintain viral suppression, through improved adherence support, service quality, monitoring, and community engagement.

    Strategic Objectives

    1. Improve Access to High-Quality ART Services

    • Ensure a consistent supply of optimal antiretroviral regimens, including first-line and second-line options.
    • Decentralize ART services and expand differentiated service delivery (DSD) models to make treatment more accessible and patient-centered.
    • Strengthen clinical management of HIV to address co-morbidities and treatment failure.

    2. Strengthen Adherence Support and Retention in Care

    • Implement adherence counselling, peer support, and community-based follow-up to improve long-term ART retention.
    • Use digital tools (SMS reminders, mobile apps) to support adherence and track missed appointments.
    • Engage family members and community networks to support treatment continuity and stigma reduction.

    3. Expand Access to Viral Load Testing

    • Scale up routine viral load testing and monitoring in line with national guidelines.
    • Ensure timely sample transport, laboratory capacity, and result turnaround to inform clinical decision-making.
    • Use viral load data to identify and respond to cases of virologic failure promptly.

    4. Train and Equip Health Providers

    • Build the capacity of healthcare workers in ART management, patient communication, and viral load interpretation.
    • Promote task-shifting and mentorship programs to optimize the use of available human resources.
    • Implement quality improvement initiatives to ensure consistent, high-standard HIV care.

    5. Strengthen Monitoring and Evaluation

    • Use national health information systems to track viral suppression rates and identify gaps across regions and populations.
    • Conduct regular cohort analyses to evaluate treatment outcomes and program effectiveness.
    • Report progress toward the 90% viral suppression target to guide policy and resource allocation.

    Expected Outcomes

    • At least 90% of PLHIV on ART achieve viral suppression by the target year.
    • Improved health outcomes and quality of life for people living with HIV.
    • Reduced HIV transmission at community level (“Undetectable = Untransmittable” or U=U).
    • Stronger and more responsive ART service delivery system.
    • Increased public confidence and engagement in the national HIV response.

    Conclusion

    Achieving 90% viral suppression among PLHIV on ART is a pivotal step toward ending AIDS as a public health threat. Neftaly is dedicated to supporting health systems, communities, and individuals to meet this target through strategic investment, innovation, and collaboration—ensuring that every person on treatment can live a long, healthy life with dignity.